Myeloperoxidase and free iron levels: Potential biomarkers for early detection and prognosis of ovarian cancer-Reference-Cited by-同舟云学术

Myeloperoxidase and free iron levels: Potential biomarkers for early detection and prognosis of ovarian cancer

Published:2012-07-09 Issue:6 Volume:10 Page:267-275
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Fletcher Nicole M.¹,Jiang Zhongliang¹,Ali-Fehmi Rouba²,Levin Nancy K.³,Belotte Jimmy¹,Tainsky Michael A.³,Diamond Michael P.¹,Abu-Soud Husam M.¹,Saed Ghassan M.¹

Affiliation:

1. Department of Obstetrics and Gynecology, The C.S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI, USA

2. Department of Pathology, Wayne State University School of Medicine, Detroit, MI, USA

3. Department of Oncology, Karmanos Cancer Institute, Detroit, MI, USA

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is there a link between talcum powder, oxidative stress, and ovarian cancer risk?;Expert Review of Anticancer Therapy;2024-05-08

2. Monomeric myeloperoxidase is a specific biomarker for early-stage ovarian cancer;Biomarkers;2023-10-03

3. The Effect of Acetylsalicylic Acid, as a Representative Non-Steroidal Anti-Inflammatory Drug, on the Activity of Myeloperoxidase;Pharmaceuticals;2023-07-17

4. The Role of Natural and Semi-Synthetic Compounds in Ovarian Cancer: Updates on Mechanisms of Action, Current Trends and Perspectives;Molecules;2023-02-22

5. RLS-0071, a dual-targeting anti-inflammatory peptide - biomarker findings from a first in human clinical trial;Translational Medicine Communications;2023-01-06